Does oxaliplatin pharmacokinetics (PKs) explain associations between body composition and chemotherapy toxicity risk in older adults with gastrointestinal (GI) cancers?
暂无分享,去创建一个
J. Meyerhardt | S. Bhatia | E. Acosta | B. Caan | W. Zamboni | G. Williams | J. Rower | S. Giri | O. Gbolahan | M. Al-Obaidi | C. Harmon | C. Dai | A. Lucas | S. S. Shachar